H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas

Pathania, Manav, De Jay, Nicolas, Maestro, Nicola, Harutyunyan, Ashot S., Nitarska, Justyna, Pahlavan, Pirasteh, Henderson, Stephen, Mikael, Leonie G. +14 more·2017·Cancer Cell
DOI 10.1016/j.ccell.2017.09.014

Cited by (265)

Items 101–200 of 265

  1. Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
    Nichole Lewis, Rachel Herndon Klein, Cailin Kelly, Jennifer Q. Yee, Paul S. Knoepfler · 2022 · Epigenetics & Chromatin
  2. Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
    Jennifer Karin Ocasio, Kaitlin M. Budd, Jordan T. Roach, Jared M. Andrews, Suzanne J. Baker · 2023 · Cancer and Metastasis Reviews
  3. High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
    Wanming Hu, Hao Duan, Sheng Zhong, Jing Zeng, Yonggao Mou · 2022 · Journal of Translational Medicine
  4. A road map for the treatment of pediatric diffuse midline glioma
    Carl Johannes Koschmann, Wajd N. Al‐Holou, Marta María Alonso, Jamie N. Anastas, Pratiti Bandopadhayay, Tara Barron, Oren Josh Becher, Rodrigo T. Cartaxo, Maria Graciela Castro, Chan Chung et al. · 2023 · Cancer Cell
  5. Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease
    Flor Mendez, Felipe Javier Núñez, María Belén Garcia-Fabiani, Santiago Haase, Stephen V. Carney, Jessica C. Gauss, Oren Josh Becher, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2019 · Neuro-Oncology
  6. Brain Tumors of Glial Origin
    Christopher A. Waker, Robert M. Lober · 2019 · Advances in experimental medicine and biology
  7. H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes
    Charles A. Day, Edward H. Hinchcliffe, James Robinson · 2022 · Cells
  8. Pioneering models of pediatric brain tumors
    Florina Grigore, Serena Johanna Yang, Clark C. Chen, Tomoyuki Koga · 2023 · Neoplasia
  9. CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
    Christine M. Hoeman, Chen Shen, Oren Josh Becher · 2018 · Frontiers in Oncology
  10. IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation
    Jung Won Park, Jiehoon Kwak, Keon Woo Kim, Saehoon Jung, Chang Hyun Nam, Hyun Jung Kim, Sang Mee Lee, Chanho Choi, Yongjin Ahn, Ji‐Hyung Park et al. · 2026 · Science
  11. Differences in survival prognosticators between children and adults with H3K27M ‐mutant diffuse midline glioma
    Xuan Gong, Shuwen Kuang, Dongfeng Deng, Jun Wu, Longbo Zhang, Chao Liu · 2023 · CNS Neuroscience & Therapeutics
  12. Preclinical therapeutic targets in diffuse midline glioma
    Michaël Hananja Meel, Gertjan J.L. Kaspers, Esther Hulleman · 2019 · Drug Resistance Updates
  13. Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
    Maya Srikanth Graham, Ingo K. Mellinghoff · 2020 · International Journal of Molecular Sciences
  14. Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
    Dennis Serge Metselaar, Aimée du Chatinier, Iris Stuiver, Gertjan J.L. Kaspers, Esther Hulleman · 2021 · Frontiers in Oncology
  15. H3.3K27M-induced chromatin changes drive ectopic replication through misregulation of the JNK pathway in C. elegans
    Kamila Delaney, Maude Strobino, Joanna M. Wenda, Andrzej Pankowski, Florian A Steiner · 2019 · Nature Communications
  16. Histone isoforms and the oncohistone code
    Andrew Flaus, Jessica A. Downs, Tom Owen‐Hughes · 2020 · Current Opinion in Genetics & Development
  17. Oncohistones in brain tumors: the soil and seed
    Augusto Faria Andrade, Carol C. L. Chen, Nada Jabado · 2023 · Trends in cancer
  18. Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
    Steffen Fuchs, Clara Danßmann, Filippos Klironomos, Annika Winkler, Jörg Fallmann, Louisa-Marie Kruetzfeldt, Annabell Szymansky, Julian Naderi, Stephan H. Bernhart, Laura Grunewald et al. · 2023 · Nature Communications
  19. The H3.3K27M oncohistone antagonizes reprogramming in Drosophila
    Kami Ahmad, Steven Henikoff · 2021 · PLoS Genetics
  20. Microglia in pediatric brain tumors: The missing link to successful immunotherapy
    Aimée du Chatinier, Irene Querol Velilla, Michaël Hananja Meel, Eelco Wieger Hoving, Esther Hulleman, Dennis Serge Metselaar · 2023 · Cell Reports Medicine
  21. The growing role of epigenetics in childhood cancers
    Eshini Panditharatna, Mariella G. Filbin · 2019 · Current Opinion in Pediatrics
  22. Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
    Zirong Chen, Peng Peng, Xiaolin Zhang, Barbara L. Mania-Farnell, Guifa Xi, Feng Wan · 2021 · Cancers
  23. Mouse Models of Experimental Glioblastoma
    Fang Jin, Helen J. Jin‐Lee, Aaron J. Johnson · 2021 · Exon Publications eBooks
  24. Fimepinostat Impairs NFκB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma
    Dan Wang, Kun Huang Yan, Hongxing Yu, Haocheng Li, Wei Zhou, Yaqiang Hong, Shuning Guo, Yi Wang, Cheng Xu, Changcun Pan et al. · 2023 · Cancer Research
  25. Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone
    Lucia Cottone, Lorena Ligammari, Hang‐Mao Lee, Helen J. Knowles, Stephen R Henderson, Sara Bianco, Christopher Davies, Sandra J. Strauss, Fernanda M Amary, Ana Paula Leite et al. · 2022 · Cell Death and Differentiation
  26. The evolutionary impact of childhood cancer on the human gene pool
    Ulrik Kristoffer Stoltze, Jon Foss-Skiftesvik, Thomas van Overeem Hansen, Simon Rasmussen, Konrad J. Karczewski, Karin Wadt, Kjeld Schmiegelow · 2024 · Nature Communications
  27. The epigenetic dysfunction underlying malignant glioma pathogenesis
    Sharvari Dharmaiah, Jason T. Huse · 2022 · Laboratory Investigation
  28. De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function
    Nils Bessler, Amber K. L. Wezenaar, Hendrikus CR Ariese, Celina Honhoff, Noëlle Dommann, Ellen J. Wehrens, Cristian Ruiz-Moreno, Thijs J M van den Broek, Raphaël V U Collot, Daan J. Kloosterman et al. · 2026 · Nature Cancer
  29. The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles’ Heel
    Paul Huchedé, Pierre Leblond, Marie Castets · 2022 · Biomedicines
  30. Histone H3K27M Mutation in Brain Tumors
    Ahmed H. K. El-Hashash · 2020 · Advances in experimental medicine and biology
  31. Simple approach for the histomolecular diagnosis of central nervous system gliomas based on 2021 World Health Organization Classification
    Maher E. Kurdi, Rana H. Moshref, Yousef Katib, Eyad Faizo, Ahmed A Najjar, Basem Bahakeem, Ahmed Khamis Bamaga · 2022 · World Journal of Clinical Oncology
  32. Contribution of histone variants to aneuploidy: a cancer perspective
    Denise Ragusa, Paola Vagnarelli · 2023 · Frontiers in Genetics
  33. Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas
    Dasun Fernando, Afsar U. Ahmed, Bryan R.G. Williams · 2024 · Frontiers in Oncology
  34. SpikeFlow: automated and flexible analysis of ChIP-Seq data with spike-in control
    Davide Bressan, Daniel Fernández-Pérez, Alessandro Romanel, Fulvio Chiacchiera · 2024 · NAR Genomics and Bioinformatics
  35. Identification of a differentiation stall in epithelial mesenchymal transition in histone H3–mutant diffuse midline glioma
    Lauren Sanders, Allison R. Cheney, Lucas Seninge, Anouk van den Bout, Marissa Chen, Holly C. Beale, Ellen Towle Kephart, Jacob Pfeil, Katrina Learned, A. Geoffrey Lyle et al. · 2020 · GigaScience
  36. The incorporation loci of H3.3K36M determine its preferential prevalence in chondroblastomas
    Yanjun Zhang, Fang Dong · 2021 · Cell Death and Disease
  37. Future Match Making: When Pediatric Oncology Meets Organoid Technology
    Virginie Barbet, Laura Broutier · 2021 · Frontiers in Cell and Developmental Biology
  38. Epigenetic mechanisms in paediatric brain tumours: regulators lose control
    Sara Badodi, Silvia Marino · 2022 · Biochemical Society Transactions
  39. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers
    Aleena K. S. Arakaki, Frank Szulzewsky, Mark R. Gilbert, Taranjit S. Gujral, Eric C. Holland · 2021 · Neuro-Oncology
  40. Chromatin Bottlenecks in Cancer
    Jay F. Sarthy, Steven Henikoff, Kami Ahmad · 2019 · Trends in cancer
  41. OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes
    Yunfei Liao, Zaili Luo, Yaqi Deng, Feng Zhang, Rohit Rao, Jiajia Wang, Lingli Xu, Shiva Senthil Kumar, Satarupa Sengupta, Mariko D DeWire-Schottmiller et al. · 2021 · Neuro-Oncology
  42. Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas
    Lia Pinto, Hanane Baidarjad, Natacha Entz‐Werlé, Eric Van Dyck · 2021 · Cancers
  43. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies
    Marta Bonada, Matilde Pittarello, Emerson De Fazio, Alessandro Gans, Paolo Alimonti, Hasan Slika, Federico Giuseppe Legnani, Francesco Di Meco, Betty Tyler · 2024 · Genes
  44. Tools to study neural and glioma stem cell quiescence.
    Dana Friess, Stephanie Brauer, Anni Pöysti, Chandra Choudhury, Lachlan Harris · 2024 · Trends in Neurosciences
  45. Microglia-glioblastoma crosstalk mediates glioblastoma invasion at the far infiltration zone
    Felix Christopher Nebeling, Falko Fuhrmann, Manuel Mittag, Fabrizio Musacchio, Henrike Antony, Nala Gockel, Lea Lydia Friker, Sonia Leonardelli, Severin Filser, A. Deli et al. · 2026 · Immunity
  46. Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas
    Syed Mohd Faisal, Flor Mendez, Fernando M. Núñez, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2020 · Oncotarget
  47. Modeling nervous system tumors with human stem cells and organoids
    Jie Duan, Yuan Wang · 2023 · Cell Regeneration
  48. A Protocol for the Generation of Treatment-naïve Biopsyderived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models
    Matthew C. Biery, Alyssa Noll, Carrie H. Myers, Shelli M. Morris, Conrad Winter, Fiona J. Pakiam, Bonnie Cole, Samuel R. Browd, James M. Olson, Nicholas Alexander Vitanza · 2020 · Journal of Experimental Neurology
  49. Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster
    Johannes Berlandi, Amel Chaouch, Nicolas De Jay, Isabel Tegeder, Katharina Thiel, Margret Shirinian, Claudia L. Kleinman, Astrid Jeibmann, Paul F. Lasko, Nada Jabado et al. · 2019 · Neuro-Oncology
  50. H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs
    Brian Krug, Bo Hu, Haifeng Chen, Claudia Negrón-Lomas, Xiao Chen, Ahmed El Mouatani, Kristjan H. Gretarsson, Adam Ptack, Shriya Deshmukh, Nisha Kabir et al. · 2026 · Nature Genetics
  51. Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management
    Bo Pang, Songyuan An, Yun Liu, Tao Jiang, Wenqing Jia, Ruichao Chai, Yongzhi Wang · 2024 · Cancer Letters
  52. PRC2-independent actions of H3.3K27M in embryonic stem cell differentiation
    Lea R Z Cohen, Binyamin Kaffe, Eden Deri, Chen Leibson, Malka Nissim‐Rafinia, Moria Maman, Nofar Harpaz, Guy Ron, Efrat Shema, Eran Meshorer · 2022 · Nucleic Acids Research
  53. Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG
    Yuxuan Deng, Jinqiu Liu, Zhuonan Pu, Yi Wang, Tian Li, Zhuang Jiang, L Z Xie, Xiaoli Zhang, Yi Chen, Mingxu Yang et al. · 2025 · Journal of Experimental & Clinical Cancer Research
  54. Current Landscape of Preclinical Models for Pediatric Gliomas: Clinical Implications and Future Directions
    Syed Mohd Faisal, Monika Yadav, Garrett R. Gibson, Adora T. Klinestiver, Ryan M. Sorenson, Evan Cantor, Maria Ghishan, John R. Prensner, Andrea T. Franson, Kevin Fate Ginn et al. · 2025 · Cancers
  55. IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline glioma
    Raphaël V U Collot, Cristian Ruiz-Moreno, Celina Honhoff, Thijs J M van den Broek, Amber K. L. Wezenaar, Daan J. Kloosterman, Hendrikus CR Ariese, Hannah Johnson, Britt M. T. Vervoort, Amal Jeiroshi et al. · 2026 · Cancer Cell
  56. Pediatric brain tumors as a developmental disease
    Marco Bruschi, Jacques Grill, Léa Guerrini‐Rousseau · 2021 · Current Opinion in Oncology
  57. Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation
    Kento Kawata, Owen S. Chapman, Satoshi Narumi, Daisuke Kawauchi · 2025 · Frontiers in Oncology
  58. Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy
    Deepak Kumar Mishra, Shelli M. Morris, Dean Popovski, Emily J Girard, Andrew Bondoc, Shiva Senthil Kumar, Augusto Faria Andrade, Xiaoting Zhu, Fupan Yao, Mi‐Youn Brusniak et al. · 2025 · Neuro-Oncology Advances
  59. Pre-Clinical Models for CAR T-Cell Therapy for Glioma
    Gust Vandecandelaere, Rishab Ramapriyan, Matthew Gaffey, Leland G. Richardson, Samuel J. Steuart, Masih Tazhibi, Adrian Kalaw, Eric P. Grewal, Jing Sun, William T. Curry et al. · 2024 · Cells
  60. Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies
    Kelsie L. Becklin, Garrett M. Draper, Rebecca A. Madden, Mitchell G. Kluesner, Tomoyuki Koga, Miller Huang, William A. Weiss, Logan G. Spector, David A. Largaespada, Branden S. Moriarity et al. · 2022 · The CRISPR Journal
  61. An imbalance between proliferation and differentiation underlies the development of microRNA-defective pineoblastoma
    Claudette R. Fraire, Kavita K. Desai, Indumathy Jagadeeswaran, Uma A Obalapuram, Lindsay K. Mendyka, Veena Rajaram, Teja Sebastian, Yemin Wang, Kenan Onel, Jeon Lee et al. · 2025 · Genes & Development
  62. The Bermuda Triangle of paediatric brain cancers: epigenetics, developmental timing window and cell of origin
    Afraah Cassim, Yolanda Colino‐Sanguino, Sarah L. Fox, Laura Rodríguez de la Fuente, Hannah E. Hartley, Fátima Valdés‐Mora · 2025 · Cancer and Metastasis Reviews
  63. An affinity for brainstem microglia in pediatric high-grade gliomas of brainstem origin
    Liat Peretz Zats, Labiba Ahmad, Natania Casden, Meelim J. Lee, Vitali Belzer, Orit Adato, Shaked Bar Cohen, Seung-Hyun B Ko, Mariella G. Filbin, Ron Unger et al. · 2022 · Neuro-Oncology Advances
  64. Chromatin mutations in pediatric high grade gliomas
    Hsiao P. J. Voon, Lee H. Wong · 2023 · Frontiers in Oncology
  65. Pediatric Glioma Models Provide Insights into Tumor Development and Future Therapeutic Strategies
    Amelia Foss, Manav Pathania · 2023 · Developmental Neuroscience
  66. Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes
    Longbo Zhang, Angélique Bordey · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  67. Indolent course of brainstem tumors with K27M‐H3.3 mutation
    Lorena Baroni, Palma Solano Paez, Liana Figueiredo Nobre, Orli Michaeli, Cynthia E Hawkins, Suzanne Laughlin, Ute Katharina Bartels, Vijay Ramaswamy, Éric Bouffet · 2019 · Pediatric Blood & Cancer
  68. Understanding the epigenetic landscape and cellular architecture of childhood brain tumors
    Gustavo Alencastro Veiga Cruzeiro, Christopher Rota, Olivia A. Hack, Rosalind A. Segal, Mariella G. Filbin · 2020 · Neurochemistry International
  69. Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup
    K. H. Brian Lam, Phedias Diamandis · 2022 · Scientific Data
  70. Rodent models of tumours of the central nervous system
    Sebastian Brandner · 2024 · Molecular Oncology
  71. Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models
    Melanie Schoof, Tuyu Zheng, Martin Sill, Roland Imle, Alessia Cais, Lea Altendorf, Alicia Fürst, Nina Hofmann, Kati Ernst, Dominik Vonficht et al. · 2025 · Nature Genetics
  72. Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer
    Anna Bobyn, Mehdi Zarrei, Yuankun Zhu, Mary Hoffman, Darren R. Brenner, Adam Cain Resnick, Stephen W. Scherer, Marco Gallo · 2020 · BMC Medical Genetics
  73. Modeling DIPG in the mouse brainstem
    Robert Siddaway, Cynthia E Hawkins · 2020 · Neuro-Oncology
  74. The mechanistic GEMMs of oncogenic histones
    Anders M. Lindroth, Yoon Jung Park, Verónica Matía, Massimo Squatrito · 2020 · Human Molecular Genetics
  75. Differentiation therapy targeting the stalled epigenetic developmental programs in pediatric high-grade gliomas
    Wang Xiang, Xiaolin Zhang, Minhai Dong, Lijun Wan, Bin Zhang, Feng Wan · 2025 · Pharmacological Research
  76. Targeting the SP/KLF Transcriptional Regulatory Network Synergizes with HDAC Inhibition to Impede Progression of H3K27M Diffuse Intrinsic Pontine Glioma
    Yu Kong, Fan Wang, Renwei Jing, Qian Zhao, Xuejiao Lv, Yingying Zhao, Ye Yuan, Xianyou Xia, Yu Sun, Yujie Tong et al. · 2025 · Cancer Research
  77. Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation ofHoxacluster genes and promotion of neuronal lineage
    Aalaa Sanad Abdallah, Herminio Joey Cardona, Samantha Gadd, Daniel Jay Brat, Plamena P. Powla, Waleed S Alruwalli, Chen Shen, David J. Picketts, Xiao‐Nan Li, Oren Josh Becher · 2023 · Neuro-Oncology Advances
  78. (B)On(e)-cohistones and the epigenetic alterations at the root of bone cancer
    Paolo Salomoni, Adrienne Margaret Flanagan, Lucia Cottone · 2023 · Cell Death and Differentiation
  79. Histone H3 mutations and their impact on genome stability maintenance
    Lucas D. Caeiro, Ramiro E. Verdún, Lluís Morey · 2024 · Biochemical Society Transactions
  80. Differences in molecular profiles of glioblastomas according to location
    Craig Horbinski · 2018 · Neuro-Oncology
  81. Diffuse intrinsic pontine glioma: Insights into oncogenesis and opportunities for targeted therapy
    Andrew P. Groves, Pratiti Bandopadhayay, Tabitha M. Cooney · 2023 · Pediatric Hematology Oncology Journal
  82. Developmental Dysregulation of Childhood Cancer
    Thomas R. W. Oliver, Sam Behjati · 2024 · Cold Spring Harbor Perspectives in Medicine
  83. Meningioma cell reprogramming and microenvironment interactions underlie brain invasion
    Ayush Aggarwal, Mark W. Youngblood, Thiébaud Picart, Hinda Najem, Sena Oten, Martha A. Cady, Stephen T. Magill, Craig Horbinski, James P. Chandler, Amy B. Heimberger et al. · 2025 · Neuro-Oncology
  84. Glioblastoma
    Elizabeth Anne Maher, Robert M. Bachoo · 2024 · Elsevier eBooks
  85. Dysregulation of chromatin organization in pediatric and adult brain tumors: oncoepigenomic contributions to tumorigenesis and cancer stem cell properties
    Seungil Paik, Francesca Maule, Marco Gallo · 2020 · Genome
  86. Histone H3 Variants in the Multiverse of Cancer
    Iva Simeonova, Geneviève Almouzni · 2024 · Annual Review of Cancer Biology
  87. Integration of Molecular Analysis, Cutting-edge Mouse Genetic Models and Proton Therapy to Improve Outcomes for Glioma Patients
    Soma Sengupta, Luke E. Pater, Daniel Pomeranz Krummel, Bruce J. Aronow, Yoshihisa Hirota, Timothy N. Phoenix, Atsuo T. Sasaki · 2021 · Exon Publications eBooks
  88. Indolent presentation of a diffuse midline glioma, H3 K27-altered
    Sudarshawn N. Damodharan, Jeffrey J. Helgager, Diane Puccetti · 2022 · Child s Nervous System
  89. Biological, Diagnostic, and Therapeutic Insights from (Epi)Genomic Profiling of Pediatric Brain Tumors
    Antonella De Cola, Amelia Foss, Richard J. Gilbertson, Manav Pathania · 2023 · Annual Review of Cancer Biology
  90. Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars
    Kasey Skinner, Tomoyuki Koga, Shunichiro Miki, Robert F. Gruener, Florina Grigore, Emma H. Torii, Davis M. Seelig, Yuta Suzuki, Daisuke Kawauchi, Benjamin Lin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Pediatric Tumors as Disorders of Development: The Case for In Vitro Modeling Based on Human Stem Cells
    Cullen D. Clairmont, Joanna J. Gell, Ching C. Lau · 2024 · Cancer Control
  92. Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironment
    Emily V. Fletcher, Chloé Shard, Yasmin Boyle, Carol J. Milligan, Ryan Stanley Cross, Anya C. Jones, Abbie Francis, Brittany Dewdney, Matt Barker, Sara Rezaeiravesh et al. · 2025 · BMC Cancer
  93. Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development
    Yan Hay Grace Lee, Maria Tsoli, Yan Chuan Shi, Chi Kin Ip, David Ziegler · 2026 · Cancer and Metastasis Reviews
  94. TRIM21 drives glioblastoma malignancy via ubiquitination-mediated PDGFRA degradation
    Qu‐Jing Gai, Chuan Wang, Si-Di Li, Bing Pang, Qiang Sun, Hong Zhou, Xin-Yue Yao, Yan Qin, Qian Yan, Yue-Xi Zhu et al. · 2026 · Cancer Letters
  95. Extracellular Vesicles in the Biology and Liquid Biopsy Diagnostics of Pediatric High‐Grade Glioma – Emerging Findings and Opportunities
    Samia Jahouri, Laura Montermini, Nadim Tawil, Mahsa Jalali, Livia Garzia, Nada Jabado, Janusz W. Rak · 2026 · Journal of Extracellular Biology
  96. FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
    Selin Jessa, Antonella De Cola, Bhavyaa Chandarana, Michael McNicholas, Steven Hébert, Adam Ptack, Damien Faury, Jessica W. Tsai, Andrey Korshunov, Timothy N. Phoenix et al. · 2024 · Cancer Research
  97. PDGFRA in paediatric high-grade glioma – target or distraction?
    Nhat Le, Jingwei Chen, Paul G. Ekert, Lauren M. Brown, Neevika Manoharan · 2025 · Neoplasia
  98. From bedside to bench: New insights in epilepsy‐associated tumors based on recent classification updates and animal models on brain tumor networks
    Silvia Cases‐Cunillera, Lea Lydia Friker, Philipp Müller, Albert J. Becker, Gerrit H. Gielen · 2024 · Molecular Oncology
  99. A disease model for Diffuse Intrinsic Pontine Glioma (DIPG) with mutations in TP53 and its application for drug repurposing
    Anton Yuryev, Anastasia P. Nesterova, Sergey Sozin, Maria Shkrob · 2022 · medRxiv
  100. Recapitulating the immune microenvironment in pediatric brain cancer: preclinical modeling strategies
    Adip Guruprasad Bhargav, Joseph S. Domino, David Akhavan, Joshua Oon Soon Goh · 2025 · Frontiers in Immunology